(Updated - April 16, 2026 6:40 AM EDT)

Oppenheimer analyst Jeff Jones initiates coverage on Aclaris Therapeutis (NASDAQ: ACRS) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments New Coverage